Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies - Schedule of Outstanding Shares of Common Stock Equivalents Excluded from Calculation (Details)

v3.22.2.2
Summary of Significant Accounting Policies - Schedule of Outstanding Shares of Common Stock Equivalents Excluded from Calculation (Details) - shares
 3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Stock options        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Anti-dilutive excluded from the calculation of diluted loss per common share (in shares) 37,755,000 21,850,000 37,755,000 21,850,000
Common shares underlying convertible debt        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Anti-dilutive excluded from the calculation of diluted loss per common share (in shares) 5,570,932 5,213,498 5,570,932 5,213,498
Warrants        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Anti-dilutive excluded from the calculation of diluted loss per common share (in shares) 136,187,225 50,213,334 136,187,225 50,213,334
Unvested restricted stock units        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Anti-dilutive excluded from the calculation of diluted loss per common share (in shares) 4,000,000 0 4,000,000 0